Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.46 |
| ▸ | FNTA | P49354 | 3/20 | 0.34 |
| ▸ | FNTB | P49356 | 3/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2672821 | 0.82 | GRIK1 (0.42) | GRIK1GRIK2FNTAFNTB | |
| SCHEMBL28663266 | 0.81 | GRIK1 (0.43) | GRIK1GRIK2FNTAFNTBFOLH1 | |
| SCHEMBL2574697 | 0.81 | GRIK1 (0.43) | GRIK1GRIK2FNTAFNTBFOLH1 | |
| SCHEMBL5367974 | 0.80 | FOLH1 (0.42) | FOLH1SLC22A6TDP1 | |
| Acetic Acid SCHEMBL28362547 | 0.80 | GRIK1 (0.46) | GRIK1GRIK2FNTAFNTBPTGS1 | |
| SCHEMBL28654110 | 0.76 | GRIK1 (0.50) | GRIK1GRIK2FNTAFNTBFOLH1 | |
| Acetic Acid SCHEMBL8154336 | 0.74 | GRIK1 (0.41) | GRIK1GRIK2FNTAFNTBPTGS1 | |
| Diethylamine SCHEMBL27889977 | 0.74 | GRIK1 (0.49) | GRIK1GRIK2FNTAFNTBFOLH1 | |
| SCHEMBL5362070 | 0.74 | MMP2 (0.39) | FOLH1SLC22A6TDP1 | |
| SCHEMBL1301946 | 0.74 | GRIK1 (0.38) | GRIK1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113527079-B | Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof | 信越化学工业株式会社 | 2023-11-14 | — | — | CN | claimed |
| EP-3901125-B1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | SHINETSU CHEMICAL CO (JP) | 2023-01-18 | — | — | EP | claimed |
| US-11286227-B2 | Processes for preparing 2-isopropenyl-5-methyl-4-hexenoic acid, 2-isopropenyl-5-methyl-4-hexen-1-ol, and a carboxylate ester thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-03-29 | — | — | US | claimed |
| EP-3901125-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-10-27 | — | — | EP | claimed |
| CN-113527079-A | Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof | 信越化学工业株式会社 | 2021-10-22 | — | — | CN | claimed |
| US-20210323902-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-10-21 | — | — | US | claimed |
| EP-3275855-B1 | METHODS FOR PRODUCING 2,6-DIMETHYL-1,5-HEPTADIEN-3-OL AND 2,6-DIMETHYL-1,5-HEPTADIEN-3-YL ACETATE | SHINETSU CHEMICAL CO (JP) | 2021-03-17 | — | — | EP | claimed |
| CN-113527079-B | Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof | 信越化学工业株式会社 | 2023-11-14 | — | — | CN | disclosed |
| EP-3901125-B1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | SHINETSU CHEMICAL CO (JP) | 2023-01-18 | — | — | EP | disclosed |
| US-11286227-B2 | Processes for preparing 2-isopropenyl-5-methyl-4-hexenoic acid, 2-isopropenyl-5-methyl-4-hexen-1-ol, and a carboxylate ester thereof | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-03-29 | — | — | US | disclosed |
| EP-3901125-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-10-27 | — | — | EP | disclosed |
| CN-113527079-A | Method for preparing 2-isopropenyl-5-methyl-4-hexenoic acid and derivative alcohol and carboxylic ester thereof | 信越化学工业株式会社 | 2021-10-22 | — | — | CN | disclosed |
| US-20210323902-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-10-21 | — | — | US | disclosed |
| WO-2015128428-A1 | PHEROMONE DISPENSER MADE OF PLASTIC MATERIAL | BASF SE (DE) | 2015-09-03 | — | — | WO | disclosed |
| EP-2384111-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2011-11-09 | — | — | EP | disclosed |
| US-20110266361-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2011-11-03 | — | — | US | disclosed |
| WO-2010076316-A1 | PHEROMONE DISPENSER | BASF SE (DE) | 2010-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323902-A1 | PROCESSES FOR PREPARING 2-ISOPROPENYL-5-METHYL-4-HEXENOIC ACID, 2-ISOPROPENYL-5-METHYL-4-HEXEN-1-OL, AND A CARBOXYLATE ESTER THEREOF | IGF1R, HPD, IGF2R | GRIK1 13/4885GRIK2 47/4885FNTA 2364/4885 |
| US-11286227-B2 | Processes for preparing 2-isopropenyl-5-methyl-4-hexenoic acid, 2-isopropenyl-5-methyl-4-hexen-1-ol, and a carboxylate ester thereof | IGF1R, HPD, IGF2R | GRIK1 13/4885GRIK2 47/4885FNTA 2364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.